143 related articles for article (PubMed ID: 32720728)
1. Uridine treatment normalizes the congenital dyserythropoietic anemia type II-like hematological phenotype in a patient with homozygous mutation in the CAD gene.
Russo R; Marra R; Andolfo I; Manna F; De Rosa G; Rosato BE; Radhakrishnan K; Fahey M; Iolascon A
Am J Hematol; 2020 Nov; 95(11):1423-1426. PubMed ID: 32720728
[No Abstract] [Full Text] [Related]
2. Function of the polypeptide chain segment connecting the dihydroorotase and aspartate transcarbamylase domains in the mammalian multifunctional CAD.
Guy HI; Evans DR
Adv Exp Med Biol; 1994; 370():729-33. PubMed ID: 7661008
[No Abstract] [Full Text] [Related]
3. CAD gene sequence and the domain structure of the mammalian multifunctional protein CAD.
Evans DR; Bein K; Guy HI; Liu X; Molina JA; Zimmermann BH
Biochem Soc Trans; 1993 Feb; 21(1):186-91. PubMed ID: 8095469
[No Abstract] [Full Text] [Related]
4. Uridine-responsive epileptic encephalopathy due to inherited variants in CAD: A Tale of Two Siblings.
McGraw CM; Mahida S; Jayakar P; Koh HY; Taylor A; Resnick T; Rodan L; Schwartz MA; Ejaz A; Sankaran VG; Berry G; Poduri A
Ann Clin Transl Neurol; 2021 Mar; 8(3):716-722. PubMed ID: 33497533
[TBL] [Abstract][Full Text] [Related]
5. CAD mutations and uridine-responsive epileptic encephalopathy.
Koch J; Mayr JA; Alhaddad B; Rauscher C; Bierau J; Kovacs-Nagy R; Coene KL; Bader I; Holzhacker M; Prokisch H; Venselaar H; Wevers RA; Distelmaier F; Polster T; Leiz S; Betzler C; Strom TM; Sperl W; Meitinger T; Wortmann SB; Haack TB
Brain; 2017 Feb; 140(2):279-286. PubMed ID: 28007989
[TBL] [Abstract][Full Text] [Related]
6. Regulation of carbamoyl phosphate synthetase by MAP kinase.
Graves LM; Guy HI; Kozlowski P; Huang M; Lazarowski E; Pope RM; Collins MA; Dahlstrand EN; Earp HS; Evans DR
Nature; 2000 Jan; 403(6767):328-32. PubMed ID: 10659854
[TBL] [Abstract][Full Text] [Related]
7. carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase (cad) regulates Notch signaling and vascular development in zebrafish.
Coxam B; Neyt C; Grassini DR; Le Guen L; Smith KA; Schulte-Merker S; Hogan BM
Dev Dyn; 2015 Jan; 244(1):1-9. PubMed ID: 25294789
[TBL] [Abstract][Full Text] [Related]
8. Triacetyluridine treats epileptic encephalopathy from CAD mutations: a case report and review.
Frederick A; Sherer K; Nguyen L; Ali S; Garg A; Haas R; Sahagian M; Bui J
Ann Clin Transl Neurol; 2021 Jan; 8(1):284-287. PubMed ID: 33249780
[TBL] [Abstract][Full Text] [Related]
9. c-myc null cells misregulate cad and gadd45 but not other proposed c-Myc targets.
Bush A; Mateyak M; Dugan K; Obaya A; Adachi S; Sedivy J; Cole M
Genes Dev; 1998 Dec; 12(24):3797-802. PubMed ID: 9869632
[TBL] [Abstract][Full Text] [Related]
10. Structural Insight into the Core of CAD, the Multifunctional Protein Leading De Novo Pyrimidine Biosynthesis.
Moreno-Morcillo M; Grande-García A; Ruiz-Ramos A; Del Caño-Ochoa F; Boskovic J; Ramón-Maiques S
Structure; 2017 Jun; 25(6):912-923.e5. PubMed ID: 28552578
[TBL] [Abstract][Full Text] [Related]
11. Key enzymes in the biosynthesis of purines and pyrimidines: their regulation by allosteric effectors and by phosphorylation.
Carrey EA
Biochem Soc Trans; 1995 Nov; 23(4):899-902. PubMed ID: 8654862
[No Abstract] [Full Text] [Related]
12. Quantitative phosphoproteomics reveal mTORC1 activates de novo pyrimidine synthesis.
Robitaille AM; Christen S; Shimobayashi M; Cornu M; Fava LL; Moes S; Prescianotto-Baschong C; Sauer U; Jenoe P; Hall MN
Science; 2013 Mar; 339(6125):1320-3. PubMed ID: 23429704
[TBL] [Abstract][Full Text] [Related]
13. CAD overexpression in mammalian cells.
Qiu Y; Davidson JN
Adv Exp Med Biol; 1998; 431():481-5. PubMed ID: 9598115
[No Abstract] [Full Text] [Related]
14. Estrogen receptor/Sp1 complexes are required for induction of cad gene expression by 17beta-estradiol in breast cancer cells.
Khan S; Abdelrahim M; Samudio I; Safe S
Endocrinology; 2003 Jun; 144(6):2325-35. PubMed ID: 12746293
[TBL] [Abstract][Full Text] [Related]
15. Identification of CAD as an androgen receptor interactant and an early marker of prostate tumor recurrence.
Morin A; Fritsch L; Mathieu JR; Gilbert C; Guarmit B; Firlej V; Gallou-Kabani C; Vieillefond A; Delongchamps NB; Cabon F
FASEB J; 2012 Jan; 26(1):460-7. PubMed ID: 21982950
[TBL] [Abstract][Full Text] [Related]
16. Heat sensitivity and Sp1 activation of complex formation at the Syrian hamster carbamoyl-phosphate synthase (glutamine-hydrolyzing)/aspartate carbamoyltransferase/dihydroorotase promoter in vitro.
Kollmar R; Lindstrom MJ; Farnham PJ
J Biol Chem; 1992 Jan; 267(1):385-91. PubMed ID: 1346130
[TBL] [Abstract][Full Text] [Related]
17. Biallelic mutations in CAD, impair de novo pyrimidine biosynthesis and decrease glycosylation precursors.
Ng BG; Wolfe LA; Ichikawa M; Markello T; He M; Tifft CJ; Gahl WA; Freeze HH
Hum Mol Genet; 2015 Jun; 24(11):3050-7. PubMed ID: 25678555
[TBL] [Abstract][Full Text] [Related]
18. Identification of the binding site for the allosteric inactivator UTP in mammalian CPS II.
Zhu LM; Carrey EA
Biochem Soc Trans; 1995 Nov; 23(4):620S. PubMed ID: 8654805
[No Abstract] [Full Text] [Related]
19. Organization and nucleotide sequence of the 3' end of the human CAD gene.
Davidson JN; Rao GN; Niswander L; Andreano C; Tamer C; Chen KC
DNA Cell Biol; 1990 Nov; 9(9):667-76. PubMed ID: 1979741
[TBL] [Abstract][Full Text] [Related]
20. Mammalian dihydroorotase: nucleotide sequence, peptide sequences, and evolution of the dihydroorotase domain of the multifunctional protein CAD.
Simmer JP; Kelly RE; Rinker AG; Zimmermann BH; Scully JL; Kim H; Evans DR
Proc Natl Acad Sci U S A; 1990 Jan; 87(1):174-8. PubMed ID: 1967494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
